Celonic is a Swiss biologics CDMO that offers end-to-end drug substance development and manufacturing solutions for monoclonal antibodies, bispecifics, and other complex molecules, including cell and gene therapies. Their offerings range from cell line development all the way to commercial manufacturing. The company supports clients globally with early discovery, upstream and downstream process development, in-house bioanalytics, formulation development, and GMP manufacturing from its state-of-the-art facilities in Basel, Switzerland, and Heidelberg, Germany.